共 50 条
- [38] Efficacy and safety of rozanolixizumab in patients with muscle-specific tyrosine kinase autoantibody-positive generalised myasthenia gravis: a subgroup analysis of the randomised, double-blind, placebo-controlled, adaptive phase III MycarinG study [J]. THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2024, 17